CLOs on the Move

New York Downtown Hospital

www.downtownhospital.org

 
New York Downtown Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. New York Downtown Hospital is based in New York, NY. You can find more information on New York Downtown Hospital at www.downtownhospital.org
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

AccelBeam Synthesis

AccelBeam Synthesis, Inc. is a Garnet Valley, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Fitness Connection

This website is for sale! fitnessconnectionusa.com is your first and best source for all of the information you’re looking for. From general topics to more of what you would expect to find here, fitnessconnectionusa.com has it all. We hope you find wha...

PharmaForce International

PharmaForce International is a Reading, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Parallel

Humans across the globe and of all walks of life want to live at their personal best, and are seeking more natural alternatives to feeling their best and getting the most out of life. Today, they are discovering the answer through natural cannabinoid products. At the same time, science and technology are unlocking the future potential of cannabinoids. We believe that cannabinoids, when used responsibly, have the power to enhance the full spectrum of well-being and to help us live healthier and happier lives. Parallel is improving the well-being of our consumers today through our proprietary, innovative brands, while planting seeds for the future through our robust innovation and high bar for business standards.

Fibrocell Science

Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.